FDA Investigator Eric C Schmitt
Eric C Schmitt has conducted inspections on 71 sites in 5 countries as of 06 Nov 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
71
Last Inspection Date:
06 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Germany,
Switzerland,
Italy,
Costa Rica
FDA Investigators that have inspected at least one site in common with Eric C Schmitt:
Abby E Pelletier,
Alice C Silva,
Althea A Williams,
Amy M Cramer,
Andrew J Garufi,
Angel Asoler Garcia,
Anthony N Onianwa,
Arie C Menachem,
Brenda P King,
Camerson E Moore,
Christopher J Cruciotti,
Darin S Wiegers,
Daryl A Dewoskin,
David P Vanhouten,
Dawn M Braswell,
Diane C Thibodeau,
Diane M Biron,
Diantha M Turner,
Dien N Nguyen,
Dolores Harper,
Dominic R Frasca,
Edmund F Mrak, Jr,
Edward J Janik,
Elizabeth B Griffin,
Ellen P Madigan,
Gale E Ryan,
George T Allen, Jr,
Helen B Ricalde,
James P Finn,
James W Whitney,
Janete F Guardia,
Jason A Rossi,
Jeffrey J Thibodeau,
John A Sciacchitano,
Jonah S Ufferfilge,
Jonathan B Lewis,
Jonathan G Matrisciano,
Justine M Corson,
Katarzyna Plona,
Kathleen E Mcafoose,
Kimberly J Langello,
Lauren M Lawrance,
Lauren M Mclaughlin,
Laurie B Frazier,
LCDR Chad N Thompson,
Lynne M Dwyer,
Marcia M Laughrey,
Maricelys Mercado,
Mark R Mcclain,
Maryam Tabatabaie,
Matthew C Watson,
Maura Rooney,
Maya M Davis,
Megan A Haggerty,
Meisha A Mandal,
Michael G Mayfield,
Michael J Leal,
Michael P Anthony,
Michael P Sweeney,
Michelle M Noe Varga,
Mutahar S Shamsi,
Nealie C Newberger,
Nicholas C Mendiola,
Pamela N Agaba,
Paul M Kawamoto,
Paul P Geraci,
Philip H Lafleur,
Preston M Lee,
Rajiv R Srivastava,
Rebecca B Welch,
Robert J Martin,
Sandra P White,
Sara M Onyango,
Shawn M Bogdan,
Sherry M Nisson,
Sonya L Karsik, RAC,
Stephen C Smith,
Suzanne M Healy,
Tamara S Rosbury,
Tanya R Syffrard,
Tina A Desorcy,
Tomika L Crafter,
Xiaojun Yan,
Yuan Fang
Eric C Schmitt's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more